Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
EHRA 2018: EHRA practical guide on non-VKA OAC
Author(s): Hein Heidbuchel Added: 5 years ago
Prof Hein Heidbuchel discusses the new EHRA practical guide on non-vitamin K antagonist oral anticoagulants. Fillmed by Radcliffe Cardiology on-site at EHRA 2018 in Barcelona, ES View more

Anticoagulation
Author(s): Demosthenes G Katritsis Added: 3 years ago
The entire field of cardiovascular medicine is witnessing an era of rapid scientific progress that occurs against a backdrop of increasing emphasis on the importance of evidence-based practice. In this context, there has been a rapid development of guidelines, scientific statements and position papers by major professional societies, such as the American College of Cardiology/American Heart… View more

Electrophysiology & Arrhythmia
Non antivitamins K Oral Anti-Coagulants - Gheorghe Andrei Dan
Author(s): Gheorghe-Andrei Dan Start date: Mar 08, 2016

Anticoagulation
Author(s): Demosthenes G Katritsis Added: 3 years ago
Reviewing recent literature of advances in arrhythmia therapy, I have found most interesting the emergence of antidotes, both general and specific, for the non-vitamin K antagonist oral anticoagulants (NOACs). NOACs offer a relative 50 % reduction in the risk of intracranial haemorrhage and haemorrhagic stroke compared with warfarin that is also maintained in the elderly. There are no clear… View more

Electrophysiology & Arrhythmia
Complications in Anticoagulated Patients with AF
Author(s): George D Katritsis , Demosthenes G Katritsis Added: 3 years ago
Atrial fibrillation (AF) is associated with a fivefold increased risk for stroke, a twofold increased risk for dementia, and a tripling of risk for heart failure,1,2,3 while AF genetic risk is strongly associated with cardioembolic stroke.4In the Framingham Heart Study the percentage of strokes attributable to AF increases steeply from 1.5% at 50–59 years of age to 23.5% at 80−89 years of age.5,6… View more

Anticoagulation
Residual Stroke Risk in Atrial Fibrillation
Author(s): Wern Yew Ding Added: 2 years ago

Electrophysiology & Arrhythmia
Percutaneous Left Atrial Appendage Occlusion: A View From the UK
Author(s): Wern Yew Ding , Dhiraj Gupta Added: 3 years ago
AF is associated with an increased risk of thromboembolic events.1,2 Risk scores are used to identify patients at high risk of such complications who may benefit from anticoagulation therapy.3 However, despite a broad range of anticoagulant options and improved uptake in anticoagulation over the past decade, there are limitations to this approach. First, there is a significant proportion of high… View more

Anticoagulation

Electrophysiology & Arrhythmia
Author(s): Marco Alings Added: 3 years ago
Atrial Fibrillation(AF) is the most common cardiac arrhythmia, with the highest prevalence in elderly patients, and is characterised by an irregular heart rhythm that may result in clots in the heart that can spread throughout the circulatory system. It is seen in approximately 2 % of the European adult population and is a significant cause of increasing healthcare costs in developed countries.1… View more

Anticoagulation

Electrophysiology & Arrhythmia
Author(s): Farhan Shahid , Gregory YH Lip Added: 3 years ago
Atrial fibrillation (AF) and heart failure (HF) are global epidemics that began more than a century ago, and their association with an ageing general population has brought about an increase in cardiovascular morbidity and rising healthcare costs.1,2 More than 50 % of patients with permanent AF have a concurrent diagnosis of HF and this proportion is expected to rise.3 It is well established that… View more

Heart Failure

Electrophysiology & Arrhythmia
How to Choose Between NOACs
Author(s): Marco Alings Added: 8 years ago

Electrophysiology & Arrhythmia